soliqua
aventis pharma - indonesia - insulin glargine, lixisenatide - larutan injeksi - 100 iu/ml /33 mcg/ml
soliqua
aventis pharma - indonesia - insulin glargine, lixisenatide - larutan injeksi - 100 iu/ml /50 mcg/ml
fluquadri
aventis pharma - indonesia - a/brisbane/02/2018 (h1n1) pdm09 like virus, a/kansas/14/2017 (h3n2) like virus (a/kansas/14/2017, x-327), b/colorado/06/2017-like virus (b/maryland/15/2016, bx-69a (victoria lineage)), b/phuket/3073/2013-like virus (b/yamagata/16/88 lineage) - suspensi injeksi - 15 mcg /15 mcg /15 mcg /15 mcg
fluquadri
aventis pharma - indonesia - cairan injeksi - 30mcg ha total per 0,25 ml dos
coaprovel tablet salut selaput 300/12,5 mg
aventis pharma - indonesia - hydrochlorothiazide; irbesartan - tablet salut selaput - 300/12,5 mg
coaprovel tablet salut selaput 150/12,5 mg
aventis pharma - indonesia - hydrochlorothiazide; irbesartan - tablet salut selaput - 150/12,5 mg
aprovel tablet salut selaput 150 mg
aventis pharma - indonesia - irbesartan - tablet salut selaput - 150 mg
aprovel tablet salut selaput 300 mg
aventis pharma - indonesia - irbesartan - tablet salut selaput - 300 mg
tetraxim
aventis pharma - indonesia - tetanus toxoid, diphteria toxoid, pertussis toxoid, filamentous haemagglutinin, inactivated poliomyelitis virus type 1 (mahoney strain), inactivated poliomyelitis virus type 2 (mef strain), inactivated poliomyelitis virus type 3 (saukett strain) - suspensi injeksi - nlt 40 iu /nlt 30 iu /25 mcg /25 mcg /40 du /8 du /32 du
aprovel
aventis pharma - indonesia - irbesartan - tablet salut selaput - 150 mg